275 related articles for article (PubMed ID: 11894150)
1. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.
Ebenroth ES; Cordes TM; Darragh RK
Pediatr Cardiol; 2001; 22(6):483-7. PubMed ID: 11894150
[TBL] [Abstract][Full Text] [Related]
2. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
[TBL] [Abstract][Full Text] [Related]
3. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
4. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia.
Krapp M; Baschat AA; Gembruch U; Geipel A; Germer U
Ultrasound Obstet Gynecol; 2002 Feb; 19(2):158-64. PubMed ID: 11876808
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
Frohn-Mulder IM; Stewart PA; Witsenburg M; Den Hollander NS; Wladimiroff JW; Hess J
Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
7. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
[TBL] [Abstract][Full Text] [Related]
8. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?
Jouannic JM; Delahaye S; Fermont L; Le Bidois J; Villain E; Dumez Y; Dommergues M
Prenat Diagn; 2003 Feb; 23(2):152-6. PubMed ID: 12575024
[TBL] [Abstract][Full Text] [Related]
9. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia.
Vigneswaran TV; Callaghan N; Andrews RE; Miller O; Rosenthal E; Sharland GK; Simpson JM
Heart Rhythm; 2014 Nov; 11(11):2047-53. PubMed ID: 25068572
[TBL] [Abstract][Full Text] [Related]
10. Flecainide as first-line treatment for fetal supraventricular tachycardia.
Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
[TBL] [Abstract][Full Text] [Related]
11. [Fetal supraventricular tachyarrhythmias refractory to initial therapy].
Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D
Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808
[TBL] [Abstract][Full Text] [Related]
12. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols.
Sridharan S; Sullivan I; Tomek V; Wolfenden J; Škovránek J; Yates R; Janoušek J; Dominguez TE; Marek J
Heart Rhythm; 2016 Sep; 13(9):1913-9. PubMed ID: 27554948
[TBL] [Abstract][Full Text] [Related]
13. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M
J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376
[TBL] [Abstract][Full Text] [Related]
14. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia.
Strizek B; Berg C; Gottschalk I; Herberg U; Geipel A; Gembruch U
Heart Rhythm; 2016 Jun; 13(6):1283-8. PubMed ID: 26829115
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK
Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730
[TBL] [Abstract][Full Text] [Related]
16. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
[No Abstract] [Full Text] [Related]
17. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
Parilla BV; Strasburger JF; Socol ML
Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
[TBL] [Abstract][Full Text] [Related]
18. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
Campbell JQ; Best TH; Eswaran H; Lowery CL
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
[TBL] [Abstract][Full Text] [Related]
19. Management of Fetal Supraventricular Tachycardia: Case Series from a Tertiary Perinatal Cardiac Center.
Broom E; Thomas JT; Petersen S; Gooi A; Ward C; Gardener G; Kostner K; Lee-Tannock A; Kumar S
Fetal Diagn Ther; 2021; 48(11-12):794-800. PubMed ID: 34753148
[TBL] [Abstract][Full Text] [Related]
20. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
Tunca Sahin G; Beattie RB; Uzun O
Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
